Nanobiotix S.A. (EPA:NANO)

Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of EUR 878.47 million. The enterprise value is 900.89 million.

Market Cap	878.47M
Enterprise Value	900.89M

Important Dates

The last earnings date was Thursday, September 18, 2025.

Earnings Date	Sep 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Nanobiotix has 48.21 million shares outstanding. The number of shares has increased by 27.99% in one year.

Current Share Class	48.21M
Shares Outstanding	48.21M
Shares Change (YoY)	+27.99%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	5.99%
Float	30.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	86.47
PB Ratio	-12.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.44
EV / Sales	88.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.48

Financial Position

The company has a current ratio of 0.63

Current Ratio	0.63
Quick Ratio	0.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.62
Interest Coverage	-5.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.64%
Return on Invested Capital (ROIC)	-567.28%
Return on Capital Employed (ROCE)	245.90%
Revenue Per Employee	98,631
Profits Per Employee	-501,388
Employee Count	108
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	-37,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +289.32% in the last 52 weeks. The beta is 1.64, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+289.32%
50-Day Moving Average	9.23
200-Day Moving Average	4.98
Relative Strength Index (RSI)	83.56
Average Volume (20 Days)	666,203

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanobiotix had revenue of EUR 10.16 million and -51.64 million in losses. Loss per share was -1.09.

Revenue	10.16M
Gross Profit	10.16M
Operating Income	-43.93M
Pretax Income	-51.68M
Net Income	-51.64M
EBITDA	-43.84M
EBIT	-43.93M
Loss Per Share	-1.09

Balance Sheet

The company has 28.82 million in cash and 51.24 million in debt, giving a net cash position of -22.42 million or -0.47 per share.

Cash & Cash Equivalents	28.82M
Total Debt	51.24M
Net Cash	-22.42M
Net Cash Per Share	-0.47
Equity (Book Value)	-68.95M
Book Value Per Share	-1.43
Working Capital	-23.15M

Cash Flow

In the last 12 months, operating cash flow was -31.13 million and capital expenditures -507,000, giving a free cash flow of -31.63 million.

Operating Cash Flow	-31.13M
Capital Expenditures	-507,000
Free Cash Flow	-31.63M
FCF Per Share	-0.66

Margins

Gross Margin	100.00%
Operating Margin	-432.39%
Pretax Margin	-508.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.99%
Shareholder Yield	n/a
Earnings Yield	-5.88%
FCF Yield	-3.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -2.82 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.82
Piotroski F-Score	1